PMEL and melanoma: Stoitzeners et al. demonstrated that an increase in immunosuppressive MDSCs within the tumor microenvironment is associated with the presence of anergic gp100-melanoma specific cytotoxic CD8+ T cells, consistent with melanoma patient data [262].